Month: February 2014

Downgrades

PRESTIGE BRANDS (PBH) Downgraded by Zacks to UNDERPERFORM

February 10, 2014 0

Zacks Investment Research downgraded shares of PRESTIGE BRANDS (PBH) from NEUTRAL to UNDERPERFORM on February 10, 2014, with a target price of $26.00. Prestige Brands Holdings is a marketer and distributor of brand name over- the-counter drug, personal care and household cleaning products sold throughout the United States and Canada. Key brands include Compound W wart remover, Chloraseptic sore-throat relief products, New-Skin liquid bandage, Clear eyes and Murine eye and ear care products, Little Remedies pediatric over-the-counter healthcare products, Cutex nail polish remover, Comet and Spic & Span household cleaner and several other well-recognized brands. […]

Upgrades

HARVEST CAP CRD (HCAP) Upgraded by Zacks to NEUTRAL

February 10, 2014 0

Zacks Investment Research upgraded shares of HARVEST CAP CRD (HCAP) from UNDERPERFORM to NEUTRAL on February 10, 2014, with a target price of $15.50. Harvest Capital Credit Corporation is a closed-end management investment company. The company invest in the form of subordinated debt, senior debt and minority equity […]

Upgrades

FIRST FINL-IND (THFF) Upgraded by Zacks to OUTPERFORM

February 10, 2014 0

Zacks Investment Research upgraded shares of FIRST FINL-IND (THFF) from NEUTRAL to OUTPERFORM on February 10, 2014, with a target price of $37.40. First Financial Corporation is a multi-bank holding company. Subsidiaries include Terre Haute First National Bank, First State Bank, First Citizens State Bank of Newport, First Farmers State Bank, First Ridge Farm State Bank, First National Bank of Marshall, First Crawford State Bank, and the Morris Plan Company […]

Stock Analysts

Canadian Solar Up on Solar Plant Sale

February 10, 2014 0

Canadian Solar Inc. ’s ( CSIQ ) share price increased 5.5% over the prior session to close at $38.87 on Feb 7, on the back of positive market sentiments relating to its sale of a solar power plant. Canadian Solar’s subsidiary Canadian Solar Solutions Inc […]

Stock Analysts

Dow Chemical Mitigates Carbon Footprint at Sochi

February 10, 2014 0

The Dow Chemical Company ( DOW ), the official chemistry company of the Olympic games, is providing its innovative technologies at the ongoing Sochi 2014 Olympic Winter Games in Russia’s Black Sea resort. Dow is offering solutions in all competition venues of the Olympic Winter Games. The market reacted positively to the news and Dow’s shares rose as much as 2% during the trading session […]

Max Keiser

Forget Chain Gang Be First On Block Chain!

February 10, 2014 0

[youtube 7J2n-6H3J0I] Watch the full Keiser Report: Tuesday In this episode of the Keiser Report, Max Keiser and Stacy Herbert discuss the ‘debate’ on Scottish Independence looking a lot like a farce as, for example, Scotland and England ‘fight’ for the right to keep the Royal Bank of Scotland. They also ask Alex Salmond, why be yet another nation on the chain gang, when you can be the first on the block chain? […]

Technicals

Is Krispy Kreme (KKD) Ready to Breakout? – Tale of the Tape

February 10, 2014 0

Krispy Kreme Doughnuts ( KKD ) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for KKD broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness. This has already started to take place, as the stock has moved lower by 9.6% in the past four weeks […]

FDA Approval

iTeos Therapeutics SA Files Patent for Immunomodulators in Cancer Immunotherapy

February 10, 2014 0

iTeos Therapeutics SA Files Patent for Immunomodulators in Cancer Immunotherapy PR Newswire GOSSELIES, Belgium, February 10, 2014 GOSSELIES, Belgium , February 10, 2014 /PRNewswire/ — iTeos Therapeutics SA today announced the filing of the Company’s first patent applications protecting proprietary inhibitors of the intracellular enzyme TDO2, which is expressed at high levels in specific cancers. iTeos Therapeutics has collaborated with Ludwig Cancer Research over the last year to identify small molecule inhibitors of the enzyme that display nanomolar potency, good selectivity, favorable pharmacokinetics profiles in rodents and activity in pharmacodynamic models. […]